» Articles » PMID: 19577518

The DosR Regulon of M. Tuberculosis and Antibacterial Tolerance

Overview
Date 2009 Jul 7
PMID 19577518
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Adaptation of Mycobacterium tuberculosis to an anaerobic dormant state that is tolerant to several antibacterials is mediated largely by a set of highly expressed genes controlled by DosR. A DosR mutant was constructed to investigate whether the DosR regulon is involved in antibacterial tolerance. We demonstrate that induction of the regulon is not required for drug tolerance either in vivo during a mouse infection or in vitro during anaerobic dormancy. Thus, drug tolerance observed in these models is due to other mechanisms such as the bacilli simply being in a non-replicating or low metabolic state. Our data also demonstrate that the DosR regulon is not essential for virulence during chronic murine infection. However, decreased lung pathology was observed in the DosR mutant. We also show that the DosR regulon genes are more highly conserved in environmental mycobacteria, than in pathogenic mycobacteria lacking a latent phase or environmental reservoir. It is possible that the DosR regulon could contribute to drug tolerance in human infections; however, it is not the only mechanism and not the primary mechanism for tolerance during a mouse infection. These data suggest that the regulon evolved not for pathogenesis or drug tolerance but for adaptation to anaerobic conditions in the environment and has been adapted by M. tuberculosis for survival during latent infection.

Citing Articles

The DosR regulon of and adaptation to hypoxia.

Belardinelli J, Avanzi C, Martin K, Lam H, Dragset M, Wheat W Front Cell Infect Microbiol. 2025; 15:1545856.

PMID: 40041152 PMC: 11876180. DOI: 10.3389/fcimb.2025.1545856.


Gene Regulatory Mechanism of Mycobacterium Tuberculosis during Dormancy.

Liu Y, Li H, Dai D, He J, Liang Z Curr Issues Mol Biol. 2024; 46(6):5825-5844.

PMID: 38921019 PMC: 11203133. DOI: 10.3390/cimb46060348.


Mycobacterial biofilms: A therapeutic target against bacterial persistence and generation of antibiotic resistance.

Sarangi A, Singh S, Das B, Rajput S, Fatima S, Bhattacharya D Heliyon. 2024; 10(11):e32003.

PMID: 38882302 PMC: 11176842. DOI: 10.1016/j.heliyon.2024.e32003.


Host stress drives tolerance and persistence: The bane of anti-microbial therapeutics.

Helaine S, Conlon B, Davis K, Russell D Cell Host Microbe. 2024; 32(6):852-862.

PMID: 38870901 PMC: 11446042. DOI: 10.1016/j.chom.2024.04.019.


DosR's multifaceted role on BCG revealed through multi-omics.

Cui Y, Dang G, Wang H, Tang Y, Lv M, Liu S Front Cell Infect Microbiol. 2023; 13:1292864.

PMID: 38076461 PMC: 10703047. DOI: 10.3389/fcimb.2023.1292864.


References
1.
Rustad T, Harrell M, Liao R, Sherman D . The enduring hypoxic response of Mycobacterium tuberculosis. PLoS One. 2008; 3(1):e1502. PMC: 2198943. DOI: 10.1371/journal.pone.0001502. View

2.
Campbell I, Bah-Sow O . Pulmonary tuberculosis: diagnosis and treatment. BMJ. 2006; 332(7551):1194-7. PMC: 1463969. DOI: 10.1136/bmj.332.7551.1194. View

3.
Voskuil M, Visconti K, Schoolnik G . Mycobacterium tuberculosis gene expression during adaptation to stationary phase and low-oxygen dormancy. Tuberculosis (Edinb). 2004; 84(3-4):218-27. DOI: 10.1016/j.tube.2004.02.003. View

4.
Wayne L, Hayes L . An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect Immun. 1996; 64(6):2062-9. PMC: 174037. DOI: 10.1128/iai.64.6.2062-2069.1996. View

5.
Landsteiner B, Olson M, Rutherford R . Current Comparative Table (CCT) automates customized searches of dynamic biological databases. Nucleic Acids Res. 2005; 33(Web Server issue):W770-3. PMC: 1160193. DOI: 10.1093/nar/gki432. View